Cite
Skrzypiec-Spring M, Urbaniak J, Sapa-Wojciechowska A, et al. Matrix Metalloproteinase-2 Inhibition in Acute Ischemia-Reperfusion Heart Injury-Cardioprotective Properties of Carvedilol. Pharmaceuticals (Basel). 2021;14(12)doi: 10.3390/ph14121276.
Skrzypiec-Spring, M., Urbaniak, J., Sapa-Wojciechowska, A., Pietkiewicz, J., Orda, A., Karolko, B., Danielewicz, R., Bil-Lula, I., Woźniak, M., Schulz, R., & Szeląg, A. (2021). Matrix Metalloproteinase-2 Inhibition in Acute Ischemia-Reperfusion Heart Injury-Cardioprotective Properties of Carvedilol. Pharmaceuticals (Basel, Switzerland), 14(12), . https://doi.org/10.3390/ph14121276
Skrzypiec-Spring, Monika, et al. "Matrix Metalloproteinase-2 Inhibition in Acute Ischemia-Reperfusion Heart Injury-Cardioprotective Properties of Carvedilol." Pharmaceuticals (Basel, Switzerland) vol. 14,12 (2021). doi: https://doi.org/10.3390/ph14121276
Skrzypiec-Spring M, Urbaniak J, Sapa-Wojciechowska A, Pietkiewicz J, Orda A, Karolko B, Danielewicz R, Bil-Lula I, Woźniak M, Schulz R, Szeląg A. Matrix Metalloproteinase-2 Inhibition in Acute Ischemia-Reperfusion Heart Injury-Cardioprotective Properties of Carvedilol. Pharmaceuticals (Basel). 2021 Dec 07;14(12). doi: 10.3390/ph14121276. PMID: 34959676.
Copy
Download .nbib